Blood tests may reveal if atypical MS is a different disease
NCT ID NCT04201470
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 28 times
Summary
This study looked at 58 people, including those with typical and atypical multiple sclerosis (MS) and healthy controls, to see if blood markers of nerve damage could help tell these conditions apart. Researchers measured two proteins in the blood: neurofilament light chain and GFAP. The goal was to understand whether people with unusual MRI findings have a more severe form of MS or a completely different disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Montpellier
Montpellier, 34000, France
Conditions
Explore the condition pages connected to this study.